Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study

AIMS: Cardiovascular (CV) hospitalization is a predictor of CV mortality and has a negative impact on patients’ quality of life. The primary endpoint of A placebo-controlled, double-blind, parallel-arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Torp-Pedersen, Christian, Crijns, Harry J.G.M., Gaudin, Christophe, Page, Richard L., Connolly, Stuart J., Hohnloser, Stefan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148817/
https://www.ncbi.nlm.nih.gov/pubmed/21576129
http://dx.doi.org/10.1093/europace/eur102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148817/
https://www.ncbi.nlm.nih.gov/pubmed/21576129
http://dx.doi.org/10.1093/europace/eur102

Ejemplares similares